Profesör Doktor, İç Hastalıkları ve Tıbbi Onkoloji Uzmanı ----
American Board of Internal Medicine (ABIM) Diplomate, Board Certified in Internal Medicine and Medical Oncology, ...[Devamı...]
Hacettepe Üniversitesi İngilizce Tıp Fakültesi’nden 1992 yılında mezun oldum. Aynı yıl Hacettepe Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı’nda İç Hastalıkları ihtisasına başladım ve 1997’de İç Hastalıkları Uzmanı oldum. Uzmanlık sonrası 1999’da Amerika Birleşik Devletleri’ne giderek Roswell Park Cancer Institute, Buffalo, New York’ta Klinik Tıbbi Onkoloji yan dal ihtisası yaptım ve 2001 yılında Tıbbi Onkoloji Uzmanı oldum. Ardından Kök Hücre ve Kemik İliği Transplantasyonu üst ihtisasını da aynı hastanede bitirdikten sonra çalışmalarıma 2003 yılına kadar ABD'de devam ettim. Aralık 2003'te Gazi Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Bilim Dalı’nda öğretim görevlisi olarak göreve başladım, Nisan 2004’te doçent oldum. Ardından 2009 yılında profesörlük kadrosuna atandım. Ağustos 2012-2013 tarihlerinde Gazi Üniversitesi Hastanesi Başhekimliği ve 2014-2016 yılları arasında aralıklarla Gazi Üniversitesi Tıp Fakültesi dekan vekilliği görevlerinde bulundum.
Hacettepe Üniversitesi Geliştirme Vakfı En İyi Klinik Araştırma Ödülü, Cancer and Leukemia Group B (CALGB) Klinik Araştırma Ödülü, American Society of Clinical Oncology (ASCO) Merit Ödülü, Roswell Park Cancer Institute Temel Bilimler En İyi Araştırma Ödülü, Mayo Clinic Fellow Ödülü, Roche Onkoloji Ödülü, Güven Hastanesi Dr. Aysun Küçükel Genç Araştırmacı Tıp Ödülü ve Güven Hastanesi En İyi Araştırma Ödülü gibi ödüllerin sahibiyim.
1. Haznedaroğlu IC, Üstündağ Y, Benekli M, Savaş MC, Safalı M, Dündar SV. Isolated gingival relapse during complete hematological remission in acute promyelocytic leukemia. Acta Haematologica 1995;93:54-55.
2. Benekli M, Savaş MC, Haznedaroğlu İC, Dündar SV. Two cases of extramedullary acute promyelocytic leukemia. Cancer 1995;76:151-152.
3. Benekli M, Savaş MC, Güllü İH, Kadayıfçı A, Akpek G, Kars A, Güler N, Kansu E, Tekuzman G, Fırat D. Tumor lysis syndrome following single-dose mitoxantrone. Chemotherapy 1995;41:470-472.
4. Haznedaroğlu İC, Benekli M, Dündar S. Thrombopoietin, megakaryocytopoietic cytokines and reactive versus clonal megakaryocytopoesis: An enigma complex. Blood 1996;87:1654.
5. Kiraz S, Ertenli İ, Benekli M, Çalgüneri M. Parvovirus B19 infection in Behçet’s disease. Clinical and Experimental Rheumatology 1996;14:71-73. ...[Devamı...]
6. Güllü İH, Benekli M, Müderrisoğlu H, Oto A, Kansu E, Kabakçı G, Oram E, Bekdik C. Silent myocardial ischemia in Behçet’s disease. Journal of Rheumatology 1996;23:323-327.
7. Kadayıfçı A, Savaş MC, Benekli M. Risks and benefits in bleeding patients on oral anticoagulation. Lancet 1996;348:1108.
8. Benekli M, Güllü İH, Savaş MC, Kadayıfçı A, Altundağ MK, Tekuzman G, Fırat D. Acute tumor lysis syndrome following intrathecal methotrexate. Leukemia&Lymphoma 1996;22:361-363.
9. Benekli M, Savaş MC, Haznedaroğlu İC, Dündar SV. Granulocytic sarcoma in acute promyelocytic leukemia. Leukemia&Lymphoma 1996;22:183-186.
10. Kadayıfçı A, Benekli M, Şimşek H, Şencan O. Prostatic acid phosphatase and prostate specific antigen in liver disease. International Urology and Nephrology 1996;28:67-71.
11. Benekli M, Büyükaşık Y, Haznedaroğlu İC, Savaş MC, Özcebe Oİ. Chronic lymphocytic leukemia presenting as acute urinary retention due to leukemic infiltration of prostate. Annals of Hematology 1996;73:143-144.
12. Kiraz S, Şimşek H, Ertenli İ, Benekli M, Kadayıfçı A, Çalgüneri M. Antineutrophil cytoplasmic antibodies in systemic sclerosis. Clinical Rheumatology 1996;15:519-20.
13. Kiraz S, Baltalı E, Güler N, Barışta İ, Benekli M, Çelik İ, Güllü İH, Kars A, Tekuzman G, Fırat D. Ifosfamide, mesna and epirubicin as second-line chemotherapy in advanced breast cancer. Journal of Chemotherapy 1996;8:310-314.
14. Haznedaroğlu İC, Savaş MC, Benekli M, Güllü İH, Dündar SV. The significance of megakaryocytopoietic cytokines and thrombopoietin in immune thrombocytopenic purpura: A hypothesis. New Zealand Medical Journal 1996;109:389.
15. Çalgüneri M, Kiraz S, Ertenli İ, Benekli M, Karaarslan Y, Çelik İ. The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet’s disease. Arthritis and Rheumatism 1996;39:2062-2065.
16. Savaş MC, Benekli M, Haznedaroğlu İC, Dündar SV. Bulky plasmacytoma of the skull with intracranial involvement. American Journal of Hematology 1997;54:173.
17. Savaş MC, Benekli M, Akçay A, Birdane A. Heparin-associated refractory bronchospasm. Annals of Pharmacotherapy 1997;31:253.
18. Benekli M, Kars A, Güler N. Mitoxantrone-induced bradycardia. Annals of Internal Medicine 1997;126:409.
19. Benekli M, Savaş MC, Haznedaroğlu İC. Extramedullary acute promyelocytic leukemia. Cancer 1997;80:518-519.
20. Haznedaroğlu İC, Savaş MC, Benekli M, Sayınalp NM, Özcebe Oİ, Dündar S. Acute lymphoblastic leukemia occurring in a case of chronic lymphocytic leukemia. Hematology 1997;2:87-89.
21. Şahin S, Hindioğlu U, Benekli M, Sivri B, Sökmensüer C, Sungur A. Peculiar inflammatory cutaneous metastasis from stomach adenocarcinoma. British Journal of Dermatology 1997;136:650-652.
22. Kadayıfçı A, Benekli M, Savaş MC, Aslan S, Uzunalimoğlu B, Barışta İ, Güllü İH, Tekuzman G. Multiple lymphomatous polyposis. Journal of Surgical Oncology 1997;64:336-340.
23. Kadayıfçı A, Arslan S, Benekli M, Sökmensüer C. Periampullary carcinoma in a patient with sarcoidosis. Sarcoidosis 1997;14:87-8.
24. Kiraz S, Baltalı E, Güler N, Barışta İ, Benekli M, Çelik İ, Güllü İH, Kars A, Tekuzman G, Fırat D. Ifosfamide and etoposide in previously treated patients with advanced breast cancer. Tumori 1997;83:604-607.
25. Savaş MC, Çelik İ, Benekli M, Kars A. Hyalinising trabecular adenoma of thyroid masquerading as thyroid carcinoma. Acta Oncologica 1997;36:436-437.
26. Öztürk MA, Benekli M, Güler N, Altundağ MK, Barışta İ, Ayhan A. Gastric adenocarcinoma metastasis to the parotid gland. Journal of Clinical Gastroenterology 1997; 25: 698-9.
27. Benekli M, Akpek G, Güllü İH, Ruacan Ş, Barışta İ, Ayhan A, Tekuzman G, Fırat D. Small intestinal perforation in a patient with Hodgkin’s disease. Journal of Clinical Gastroenterology 1997;25:699-701.
28. Haznedaroğlu İC, Savaş MC, Benekli M. Renin-like activity in leukemic blast cells: An initial clue for a local renin-angiotensin system in the bone marrow. Annals of Hematology 1997;75:69-70.
29. Çalgüneri M, Kiraz S, Ertenli İ, Benekli M, Karaarslan Y, Çelik İ. Reply: letter to the editor. Arthritis and Rheumatism 1997;40:1728-1730.
30. Benekli M, Güllü İH. Hippocratic fingers in Behçet’s disease. Postgraduate Medical Journal 1997;73:575-576.
31. Haznedaroğlu İC, Büyükaşık Y, Benekli M, Güllü İH. Real-Working classification of lymphoid neoplasms: The golden prefix. Journal of National Cancer Institute 1997;89:1546.
32. Benekli M, Yalçın B, Güler N, Tekuzman G. Disseminated morphea in small cell lung cancer. Acta Dermato-Venereologica 1998;78:72-73.
33. Benekli M, Savaş MC, Erdem Y, Yalçın AU, Yasavul Ü, Turgan Ç, Çağlar Ş. Primary hyperparathyroidism in a patient with systemic lupus erythematosus-antiphospholipid syndrome. Nephron 1998;79:215-216.
34. Savaş MC, Çelik İ, Benekli M, Güllü İH, Tekuzman G. Renal cell carcinoma presenting as a solitary cervical node metastasis compressing brachial plexus. Nephron 1998;79:107-108.
35. Öztürk MA, Benekli M, Altundağ MK, Güler N. Squamous cell carcinoma in a patient with systemic sclerosis. Dermatologic Surgery 1998;24:777-779.
36. Benekli M, Güllü İH, Tekuzman G, Savaş MC, Hayran M, Hasçelik G, Fırat D. Circulating intercellular adhesion molecule-1 and E-selectin in gastric cancer. British Journal of Cancer 1998;78:267-271.
37. Benekli M, Güllü İH, Haznedaroğlu İC. Ischemic heart disease in Behçet’s syndrome. Rheumatology International 1998;17:251.
38. Benekli M, Haznedaroğlu İC, Erdem Y. Glomerular disease in Behçet’s disease (Invited Editorial Comment). Nephrology Dialysis Transplantation 1998;13:1351-1354.
39. Barışta İ, Benekli M, Tekuzman G. Amyloidosis in Hodgkin’s and Castleman’s diseases. Annals of Oncology 1999;10:998-999.
40. Kiraz S, Ertenli İ, Benekli M, Haznedaroğlu İC, Çalgüneri M, Çelik İ, Apraş Ş, Kirazlı Ş. Clinical significance of hemostatic markers and thrombomodulin in systemic lupus erythematosus: Evidence for a prothrombotic state. Lupus 1999;8:737-741.
41. Haznedaroğlu İC, Benekli M, Ozcebe O, Savaş MC, Güllü İH, Dündar SV, Kirazlı Ş. Serum L-selectin and P-selectin levels in lymphomas. Haematologia 2000;30:27-30.
42. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy PL. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplantation 2000;25:1299-1301.
43. Benekli M, Xia Z, Donohue KA, Ford LA, Pixley LA, Baer MR, Baumann H, Wetzler M. Constitutive activity of signal transducer and activator of transcription (STAT) 3 protein in acute myeloid leukemia (AML) blasts is associated with short disease-free survival. Blood 2002;99:252-57.
44. Haznedaroglu IC, Goker H, Turgut M, Buyukasik Y, Benekli M. Thrombopoietin as a drug: biologic expectations, clinical realities, and future directions. Clinical and Applied Thrombosis Haemostasis 2002;8:193-212.
45. Benekli M, Baer MR, Baumann H, Wetzler M. Signal transducer and activatorof transcription proteins in leukemias. Blood 2003;101:2940-2954.
46. Shaukat A, Benekli M, Vladutiu GD, Slack JL, Wetzler M, Baer MR. Drug interaction between simvastatin and fluconazole causing rhabdomyolysis. Annals of Pharmacotherapy 2003;37:1032-1035.
47. Benekli M, Hahn T, Shafi F, Qureshi A, Alam AR, Czuczman MS, Bernstein ZP, Chanan-Khan AA, Becker JL, McCarthy PL Jr. The effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin lymphoma patients. Bone Marrow Transplantation 2002;32:139-143.
48. Benekli M, Crane JK, Conti RR, Kremzier JE, Bidani R. Pulmonary mucormycosis in a patient with chronic obstructive pulmonary disease: diagnosis by fine needle aspiration cytology. Journal of Thoracic and Cardiovascular Surgery 2004;127:588-9.
49. Benekli M, Hahn T, Wong C, Moysich KB, Hyland A, Michalek AM, Alam A, Baer MR, Bambach B, Czuczman MS, Wetzler M, Becker JL, McCarthy, Jr PL. A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin’s disease. Bone Marrow Transplantation 2005;35:557-66.
50. Oktar SO, Yucel C, Demiroğullari T, Uner A, Benekli M, Erbas G, Ozdemir H. Doppler sonographic evaluation of hemodynamic changes in colorectal liver metastases relative to liver size. Journal of Ultrasound Medicine 2006;25:575-82.
51. Benekli M, Hahn T, Williams BT, Cooper M, Roy HN, Wallace P, Stewart C, Bambach B, McCarthy, Jr PL. Muromonab-CD3 (Orthoclone OKT3®), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation. Bone Marrow Transplantation 2006;38:365-370.
52. Yolcu OF, Koklu S, Yuksel O, Coban S, Ayaz S, Ozturk MA, Benekli M. Vascular endothelial growth factor receptor-1 levels in hepatocellular carcinoma and correlations with clinicopathological features. Hepatogastroenterology 2007;54:1526-1528
53. Yaman E, Uner A, Er O, Coskun U, Buyukberber S, Dikilitas M, Polat M, Yamac D, Kaya AO, Yildiz R, Ozturk B, Benekli M. Capecitabine plus oxaliplatin (XELOX) in the treatment of chemotherapy-naïve patients with metastatic colorectal cancer. Medical Oncology 2007;24:431-435.
54. Benekli M, Yildiz R, Uner A, Er O, Yamac D, Alkis N, Coskun U, Camci C, Buyukberber S. Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Oncology (Basel) 2007;72:308-13.
55. Coskun U, Buyukberber S, Yaman E, Er O, Uner A, Ozkan M, Dikilitas M, Oguz M, Yildiz R, Benekli M. XELOX (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients. Neoplasma 2008;55:65-70.
56. Yildiz R, Coskun U, Kapucu O, Kaya AO, Akdemir UO, Benekli M, Buyukberber S. F-18 FDG uptake due to Acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient. Clinical Nuclear Medicine2007;32:471-473.
57. Yaman E, Coskun U, Buyukberber S, Ozturk B, Kaya AO, Yildiz R, Uner A, Yamac D, Benekli M. Persistent elevation of CA 19-9 in an apparently healthy 56-year-old woman. LabMedicine 2007;38: 485-486.
58. Ozturk B, Buyukberber S, Coskun U, Yaman E, Yildiz R, Kaya AO, Oner Y, Benekli M. Solitary iris metastasis from breast cancer with dramatic course: case report. Medical Oncology. 2007;24:463-465.
59. Uner A, Ozturk B, Benekli M, Coskun U, Kocak S, Kaya AO, Unsal D, Erekul S, Yaman E, Yildiz R, Buyukberber S. Synchronized primary breast osteosarcoma and contralateral benign cystosarcoma phyllodes: Radiological and pathological imaging. Breast Journal 2008;14:109-110.
60. Yaman E, Benekli M, Coskun U, Ozturk B, Kaya AO, Yildiz R, Buyukberber S. Reply to the article "Oral ibandronate is as active as i.v. zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases" by J.-J. Body et al. Annals of Oncology 2008;19:397-398
61. Benekli M, Smiley S, Younis T, Czuczman MS, Hernandez-Ilizaliturri F, Bambach B, Battiwalla M, Padmanabhan S, McCarthy, PL Jr, Hahn T. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma. Bone Marrow Transplantation2008;41:613-619.
62. Ozturk B, Buyukberber S, Akmansu M, Coskun U, Yamac D, Uner A, Yaman E, Yildiz R, Kaya AO, Bora H, Unsal D, Pak Y, Benekli M. The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma. Medical Oncology 2008;25:269-273.
63. Coskun U, Kaya AO, Buyukberber S, Benekli M, Uner A, Dikilitas M, Ozturk B, Yildiz R, Ozkan S, Yaman E, Yamac D. Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimens. Medical Oncology2008;25:133-136.
64. Berk V, Yildiz R, Akdemir UO, Akyurek N, Karabacak NI, Coskun U, Benekli M. Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: Utility of 18F-FDG PET in staging. Clinical Nuclear Medicine 2008;33:365-366.
65. Yaman E, Buyukberber S, Uner A, Coskun U, Akmansu M, Uncu D, Zengin N, Benekli M, Yamac D, Ozturk B, Kaya AO, Yildiz R, Ozkan S, Gunel N. Temozolomide in newly diagnosed malignant gliomas administered concomitantly with radiotherapy and thereafter as consolidation treatment. Onkologie 2008;31:309-313.
66. Yaman E, Buyukberber S, Uner A, Coskun U, Yamac D, Ozturk B, Kaya AO, Yildiz R, Benekli M. Carboplatin and oral cyclophosphamide combination after temozolomide failure in malignant gliomas. Tumori 2008;94:674-680.
67. Coskun U, Buyukberber S, Yaman E, Er O, Uner A, Ozkan M, Dikilitas M, Oguz M, Yildiz R, Benekli M. XELOX (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients. Neoplasma 2008;55:65-70.
68. Kaya AO, Coskun U, Unlu M, Akdemir UO, Ozdemir NY, Zengin N, Benekli M, Yildiz R, Yaman E, Ozturk B, Gumus M, Uner A, Yamac D, Ucgul E, Buyukberber S. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with metastatic carcinoma of unknown origin. Asian Pacific Journal of Cancer Prevention 2008;9:683-686.
69. Bostankolu Ö, Öztürk B, Coşkun U, Buyukberber S, Benekli M. Cancer chemotherapy in elderly patients. International Journal of Hematology and Oncology 2008;18:186-192.
70. Kaya AO, Yıldız R, Öztürk B, Yaman E, Barıt G, Coşkun U, Üner A, Benekli M, Yamaç D, Büyükberber S. Synchronous squamous cell lung carcinoma and rectum adenocarcinoma: case report. International Journal of Hematology and Oncology 2008;18:42-45.
71. Yaman E, Benekli M, Coskun U, Sezer K, Ozturk B, Kaya AO, Yildiz R, Uluoglu O, Buyukberber S. Intrasellar plasmacytoma: an unusual presentation of multiple myeloma. Acta Neurochirurgica (Wien) 2008;150:921-924.
72. Kaya AO, Buyukberber S, Coskun U, Yildiz R, Ozturk B, Yaman E, Adisen E, Gureli M, Benekli M. Acute erythema and edematous skin reaction and ectropion following docetaxel in a patient with non-small cell lung cancer. Cutaneous and Ocular Toxicology 2008;27:327-331.
73. Yaman E, Ozturk B, Erdem O, Gokcora N, Coskun U, Uluoglu O, Benekli M. Histiocytic sarcoma: PET-CT evaluation of a rare entitiy. Annals of Nuclear Medicine 2008;22:715-717.
74. Yaman E, Coskun U, Benekli M, Sozen S, Yamac D, Buyukberber S, Ozturk B, Kaya AO, Yildiz R, Tezel E. Coexistence of gastrointestinal stromal tumor of rectum and adenocarcinoma of prostate in a patient with family history of gastrointestinal stromal tumor. Onkologie 2008;31:697-699.
75. Ozturk B, Tacoy G, Coskun U, Yaman E, Sahin G, Buyukberber S, Yildiz R, Kaya AO, Topal S, Ozdemir M, Benekli M. Gemcitabine-induced acute coronary syndrome: a case report. Medical Principles and Practice 2009;18:76-80.
76. Yaman E, Coskun U, Ozturk B, Buyukberber S, Kaya AO, Coskun O, Buyukberber N, Yildiz R, Benekli M. Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. Journal of Clinical Neuroscience 2009;16:591-592.
77. Ozturk B, Coskun U, Sancak B, Yaman E, Buyukberber S, Benekli M. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors. International Immunopharmacology 2009;9:645-648.
78. Yildiz R, Benekli M, Akyurek N, Coskun U, Kaya AO, Ozturk B, Yaman E, Buyukberber S. Non-gestational uterine choriocarcinoma in a postmenopausal woman: a case report. Onkologie 2009;32:417-419.
79. Karaoglu A, Arslan UY, Ozkan M, Kalender ME, Alici S, Coskun U, Gumus M, Celenkoglu G, Er O, Sevinc A, Buyukberber S, Alkis N, Benekli M. Efficacy and toxicity of gemcitabine and pgylated liposomal doxorubicin in recurrent platinum-resistant/refractory epithelial ovarian cancer. Asian Pacific Journal of Cancer Prevention 2009;10:63-66.
80. Ozturk B, Coskun U, Yaman E, Kaya AO, Yildiz R, Benekli M, Buyukberber S. The risk factors, premalignant lesions and chemoprevention oral cavity cancers. International Journal of Hematology and Oncology 2009;19:117-126.
81. Kaya AO, Coskun U, Sancak B, Buyukberber S, Yildiz R, Gulbahar O, Benekli M, Ozenirler S. Increased serum granulocyte colony stimulating factor in Turkish hepatocellular carcinoma patients. Asian Pacific Journal of Cancer Prevention 2009;10:403-405.
82. Benekli M, Baumann H, Wetzler M. Targeting signal transducer and activator of transcription signaling pathway in leukemias. Journal of Clinical Oncology 2009;27:4422-4432.
83. Ozturk B, Coskun U, Yaman E, Cakir A, Akdemir UO, Yildiz R, Akyol G, Demirci U, Buyukberber S, Tezel E, Benekli M. Adult hepatic epitheloid haemangioendothelioma presenting with Kasabach-Merrit syndrome: a case report. Journal of Clinical Pathology 2009;62(11): 1053-1055.
84. Coskun U, Alkis N, Celenkoglu G, Buyukberber S, Ozkan M, Camci C, Uner A, Er O, Aslan UY, Sevinc A, Tokluoglu S, Ozturk B, Yildiz R, Benekli M. Gemcitabine combined with uracil-tegafur (UFT) in patients with advanced pancreatic cancer. Journal of National Medical Association 2009;101:761-764.
85. Demirci U, Coskun U, Sancak B, Ozturk B, Bahar B, Benekli M, Buyukberber S. Serum granulocyte macrophage-colony stimulating factor: a tumor marker in colorectal carcinoma? Asian Pacific Journal of Cancer Prevention 2009;10:1021-1024.
86. Alici S, Coskun U, Alkis N, Sevinc A, Dane F, Gumus M, Ozkan M, Kaya AO, Celenkoglu G, Buyukberber S, Altinbas M, Benekli M. Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas. Asian Pacific Journal of Cancer Prevention 2009;10;1051-1055.
87. Coskun U, Kaya AO, Alkis N, Buyukberber S, Alici S, Celenkoglu G, Uncu D, Ozkan M, Sevinc A, Benekli M. UFT plus oral folinic acid alternating oral and intravenous vinorelbine in patients with metastatic breast cancer previously treated with anthracycline and taxanes. Onkologie 2009;32:562-566.
88. Kaya AO, Buyukberber S, Benekli M, Coskun U, Sevinc A, Akmansu M, Yildiz R, Ozturk B, Yaman E, Kalender ME, Orhan O, Yamac D, Uner A. Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally-advanced non-small cell lung cancer. Medical Oncology 2010;27:152-157.
89. Demirci U, Büyükberber S, Yılmaz G, Oztürk B, Akyürek N, Yıldız R, Tonyalı O, Coşkun U, Benekli M. Coexistence Hodgkin's lymphoma and colonic adenocarcinoma: a case report. Medical Oncology 2010;27:62-64.
90. Baykara M, Coskun U, Demirci U, Yildiz R, Benekli M, Cakir A, Buyukberber S. Intracystic papillary carcinoma of the breast: one of the youngest patient in the literature. Medical Oncology 2010;27:1427-1428.
91. Yildiz R, Buyukberber S, Uner A, Yamac D
Üye Oldugu Mesleki Kuruluş ve Organizasyonlar
European Society of Medical Oncology (ESMO)
Türk Tıbbi Onkoloji Derneği (TTOD)
Türk Onkoloji Grubu (TOG)
Türk Hematoloji Derneği (THD)
Türk İç Hastalıkları Uzmanlık Derneği (TİHUD)
Uzmana Gönderilen Mesaj
Dr.Mustafa BENEKLİ'nin Tavsiye Ettiği Uzmanlar
Özel Uzmanlık ve Çalışma Alanları 
Dr.Mustafa BENEKLİ'nin Özgeçmişi
Dr.Mustafa BENEKLİ'nin Makale ve Yazıları 
Tavsiye ve Teşekkürler
Dr.Mustafa BENEKLİ'nin Basılı Kitap ve Yayınları
Üye Oldugu Mesleki Kuruluş ve Organizasyonlar 
Videoları
Kanser Üzerine Söyleşi
Yabancı Dil 
